A struggle with the BP+ is that it covers an area that is still highly academic.
But there are examples of evolving commercialisation of this area. Such as HealthScreeningNZ recently launching with 3PHealthCare's new app in conjunction with the BP+ for better quality cardiovascular health screenings. They are also partnering with pharmacies which involves selling them a BP+.
https://www.healthscreeningnz.com/
If this sort of thing can be brought across to China in a big way it could be very significant. Especially since Asian nations seem to have a thing for "over screening" compared to western nations.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable